Brand name (Generic drug name)


Active Ingredient: brolucizumab

Drug Class: Ophthalmological / Antineovascularization Agents

This drug is not on the Reformulary. Our Expert Committee did an extensive review of the clinical and cost-effectiveness evidence, and recommended not to fund due to lack of evidence.

BEOVU is used
to treat various eye conditions, such as wet AMD